Literature DB >> 15680679

Coffee diterpenes prevent the genotoxic effects of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) and N-nitrosodimethylamine in a human derived liver cell line (HepG2).

B J Majer1, E Hofer, C Cavin, E Lhoste, M Uhl, H R Glatt, W Meinl, S Knasmüller.   

Abstract

Aim of the present experiments was to study the genotoxic effects of coffee diterpenoids, namely cafestol palmitate and a mix of cafestol and kahweol (C+K) in human derived hepatoma (HepG2) cells. Furthermore, we investigated the potential protective properties of these substances towards carcinogens contained in the human diet, namely N-nitrosodimethylamine (NDMA) and 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP). C+K and cafestol palmitate were tested over a broad dose range in micronucleus (MN) assays and no indication for genotoxic effects was seen. In combination experiments with PhIP (300 microM), pronounced inhibition (approximately 1.7-fold) of MN formation was observed with C+K and cafestol palmitate at dose levels > or = 0.9 and 1.7 microg/ml, respectively. Enzyme measurements indicate that the protection is due to inhibition of sulfotransferase, an enzyme involved in the activation of the amine, and/or to induction of UDP-glucuronosyltransferase which detoxifies the DNA-reactive metabolites of PhIP. Furthermore, a significant increase of glutathione-S-transferase was seen, whereas the activities of cytochrome P-450 1A1 and N-acetyltransferase 1 were not significantly altered. Also in combination experiments with C+K and NDMA, strong protective effects (50% reduction of genotoxicity) were seen at low dose levels (> or = 0.3 microg/ml). Since inhibition of MN was also observed when C+K were added after incubation with NDMA, it is likely that the chemoprotective effects are due to induction of DNA repair enzymes. Comparison of data on the effects of C+K on the cholesterol metabolism, which was investigated in earlier in vivo studies, with the present findings suggests that DNA-protective effects take place at exposure levels which are substantially lower than those which cause hypercholesterolemia.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15680679     DOI: 10.1016/j.fct.2004.11.009

Source DB:  PubMed          Journal:  Food Chem Toxicol        ISSN: 0278-6915            Impact factor:   6.023


  20 in total

1.  Coffee provides a natural multitarget pharmacopeia against the hallmarks of cancer.

Authors:  François Gaascht; Mario Dicato; Marc Diederich
Journal:  Genes Nutr       Date:  2015-11-17       Impact factor: 5.523

Review 2.  Hepatocellular carcinoma: epidemiology, risk factors and pathogenesis.

Authors:  Asmaa-Ibrahim Gomaa; Shahid-A Khan; Mireille-B Toledano; Imam Waked; Simon-D Taylor-Robinson
Journal:  World J Gastroenterol       Date:  2008-07-21       Impact factor: 5.742

3.  Coffee and liver - long way to go.

Authors:  Ajay K Duseja
Journal:  J Clin Exp Hepatol       Date:  2012-09-21

4.  Coffee and tea intake and risk of head and neck cancer: pooled analysis in the international head and neck cancer epidemiology consortium.

Authors:  Carlotta Galeone; Alessandra Tavani; Claudio Pelucchi; Federica Turati; Deborah M Winn; Fabio Levi; Guo-Pei Yu; Hal Morgenstern; Karl Kelsey; Luigino Dal Maso; Mark P Purdue; Michael McClean; Renato Talamini; Richard B Hayes; Silvia Franceschi; Stimson Schantz; Zuo-Feng Zhang; Gilles Ferro; Shu-Chun Chuang; Paolo Boffetta; Carlo La Vecchia; Mia Hashibe
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-06-22       Impact factor: 4.254

5.  Coffee intake and gastric cancer risk: the Singapore Chinese health study.

Authors:  Cheryl E Ainslie-Waldman; Woon-Puay Koh; Aizhen Jin; Khay Guan Yeoh; Feng Zhu; Renwei Wang; Jian-Min Yuan; Lesley M Butler
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-03-08       Impact factor: 4.254

6.  Coffee consumption and the risk of cancer in the Norwegian Women and Cancer (NOWAC) Study.

Authors:  Marko Lukic; Idlir Licaj; Eiliv Lund; Guri Skeie; Elisabete Weiderpass; Tonje Braaten
Journal:  Eur J Epidemiol       Date:  2016-03-24       Impact factor: 8.082

7.  Dose-response meta-analysis of coffee consumption and risk of colorectal adenoma.

Authors:  Yong Wang; Jing Chen; Rui Zhao; Lin Xia; Ya-Ping Cui; Zhi-Yong Rao; Yong Zhou; Xiao-Ting Wu
Journal:  Eur J Clin Nutr       Date:  2019-07-15       Impact factor: 4.016

8.  Bladder cancer, GSTs, NAT1, NAT2, SULT1A1, XRCC1, XRCC3, XPD genetic polymorphisms and coffee consumption: a case-control study.

Authors:  Loredana Covolo; Donatella Placidi; Umberto Gelatti; Angela Carta; Antonio Scotto Di Carlo; Paolo Lodetti; Antonio Piccichè; Grazia Orizio; Marcello Campagna; Cecilia Arici; Stefano Porru
Journal:  Eur J Epidemiol       Date:  2008       Impact factor: 8.082

9.  Coffee intake and risk of colorectal cancer among Chinese in Singapore: the Singapore Chinese Health Study.

Authors:  Sabrina Peterson; Jian-Min Yuan; Woon-Puay Koh; Can-Lan Sun; Renwei Wang; Robert J Turesky; Mimi C Yu
Journal:  Nutr Cancer       Date:  2010       Impact factor: 2.900

10.  Coffee consumption and risk of rare cancers in Scandinavian countries.

Authors:  Marko Lukic; Lena Maria Nilsson; Guri Skeie; Bernt Lindahl; Tonje Braaten
Journal:  Eur J Epidemiol       Date:  2018-02-23       Impact factor: 8.082

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.